Suchergebnisse - "Yokoyama, Keitaro"

PubPharm (13)

1

A 12-week dose-escalating study of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese hemodialysis patients 

enthalten in: Clinical nephrology | 2017

von Yokoyama, K. | Fukagawa, M. | Shigematsu, T. | +4

2

The differences in acid-base status and the calcium parathyroid axis between peritoneal dialysis and hemodialysis

enthalten in: Clinical nephrology | 2016

von Morishita, M. | Matsuo, N. | Maruyama, Y. | +7

3

The differences in acid-base status and the calcium parathyroid axis between peritoneal dialysis and hemodialysis

enthalten in: Clinical nephrology | 2016

von Morishita, M. | Matsuo, N. | Maruyama, Y. | +7

4

The differences in acid-base status and the calcium parathyroid axis between peritoneal dialysis and hemodialysis

enthalten in: Clinical nephrology | 2016

von Morishita, M. | Matsuo, N. | Maruyama, Y. | +7

5

Efficacy and safety of lanthanum carbonate in pre-dialysis CKD patients with hyperphosphatemia : a randomized trial

enthalten in: Clinical nephrology | 2014

von Takahara, Y. | Matsuda, Y. | Takahashi, S. | +42

6

Do serum hepcidin-25 levels correlate with oxidative stress in patients with chronic kidney disease not receiving dialysis?

enthalten in: Clinical nephrology | 2012

von Maruyama, Y. | Yokoyama, K. | Yamamoto, H. | +2

7

Cinacalcet for hemodialyzed patients with or without a high PTH level to control serum calcium and phosphorus : ECO (evaluation of cinacalcet HCl outcome) study

enthalten in: Clinical nephrology | 2012

von Yokoyama, K. | Ohkido, I. | Ishida, M. | +7

8

Decrease of serum sphingosine-1-phosphate levels in hemodialysis patients with secondary hyperparathyroidism treated with cinacalcet

enthalten in: Clinical nephrology | 2012

von Yokoyama, K. | Ohkido, I. | Iwamoto, T. | +3

9

Serum soluble α-klotho in hemodialysis patients

enthalten in: Clinical nephrology | 2012

von Yokoyama, K. | Imura, A. | Ohkido, I. | +7

10

Letter to the Editor - Decrease of serum sphingosine-1-phosphate levels in hemodialysis patients with secondary hyperparathyroidism treated with cinacalcet

enthalten in: Clinical nephrology | 2012

von Yokoyama, K. | Ohkido, I. | Iwamoto, T. | +3